Psyence Biomedical Ltd.
PBM
$0.5168
-$0.0165-3.09%
NASDAQ
| 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 2.85M | 2.14M | 1.64M | 1.65M | 1.66M |
| Depreciation & Amortization | 2.10K | 1.10K | 200.00 | 100.00 | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 3.41M | 2.43M | 2.19M | 2.84M | 3.50M |
| Operating Income | -3.41M | -2.43M | -2.19M | -2.84M | -3.50M |
| Income Before Tax | -47.92M | -48.38M | -50.66M | -27.16M | -3.67M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -47.92 | -48.38 | -50.66 | -27.16 | -3.67 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -47.92M | -48.38M | -50.66M | -27.16M | -3.67M |
| EBIT | -3.41M | -2.43M | -2.19M | -2.84M | -3.50M |
| EBITDA | -3.40M | -2.25M | -1.28M | -632.10K | -- |
| EPS Basic | -270.58 | -272.83 | -298.45 | -178.84 | -40.14 |
| Normalized Basic EPS | -7.43 | -5.25 | -3.25 | -14.14 | -13.09 |
| EPS Diluted | -270.58 | -272.83 | -298.45 | -178.84 | -40.14 |
| Normalized Diluted EPS | -7.43 | -5.25 | -3.25 | -14.14 | -13.09 |
| Average Basic Shares Outstanding | 864.40K | 766.20K | 535.50K | 423.70K | 245.20K |
| Average Diluted Shares Outstanding | 864.50K | 766.20K | 602.20K | 490.40K | 311.90K |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |